IL133138A0 - Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor - Google Patents
Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitorInfo
- Publication number
- IL133138A0 IL133138A0 IL13313898A IL13313898A IL133138A0 IL 133138 A0 IL133138 A0 IL 133138A0 IL 13313898 A IL13313898 A IL 13313898A IL 13313898 A IL13313898 A IL 13313898A IL 133138 A0 IL133138 A0 IL 133138A0
- Authority
- IL
- Israel
- Prior art keywords
- thiazolidinedione
- diabetes
- alpha
- treatment
- glucosidase inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9712865.6A GB9712865D0 (en) | 1997-06-18 | 1997-06-18 | Novel method of treatment |
| GBGB9806708.5A GB9806708D0 (en) | 1998-03-27 | 1998-03-27 | Novel method |
| PCT/EP1998/003691 WO1998057635A1 (en) | 1997-06-18 | 1998-06-15 | Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL133138A0 true IL133138A0 (en) | 2001-03-19 |
Family
ID=26311746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13313898A IL133138A0 (en) | 1997-06-18 | 1998-06-15 | Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0975343A1 (en) |
| JP (1) | JP2001523271A (en) |
| KR (1) | KR20010013845A (en) |
| CN (1) | CN1274282A (en) |
| AP (1) | AP9901720A0 (en) |
| AR (2) | AR013352A1 (en) |
| AU (1) | AU8799998A (en) |
| BG (1) | BG103966A (en) |
| BR (1) | BR9810186A (en) |
| CA (1) | CA2294134A1 (en) |
| CO (1) | CO4940453A1 (en) |
| DZ (1) | DZ2519A1 (en) |
| EA (1) | EA200000040A1 (en) |
| IL (1) | IL133138A0 (en) |
| MA (1) | MA26510A1 (en) |
| NO (1) | NO996270D0 (en) |
| NZ (1) | NZ501345A (en) |
| OA (1) | OA11631A (en) |
| PE (1) | PE89199A1 (en) |
| PL (1) | PL337577A1 (en) |
| SK (1) | SK179499A3 (en) |
| TR (1) | TR199903072T2 (en) |
| UY (1) | UY25051A1 (en) |
| WO (1) | WO1998057635A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60037602T2 (en) | 1999-04-23 | 2009-01-08 | Smithkline Beecham P.L.C., Brentford | Preparation of a polymorphic form of a thiazolidinedione derivative |
| DE60233655D1 (en) | 2001-04-04 | 2009-10-22 | Ortho Mcneil Janssen Pharm | R AND RETINOID X RECEPTOR MODULATORS |
| DE60231295D1 (en) | 2001-04-04 | 2009-04-09 | Ortho Mcneil Janssen Pharm | R AND PPAR MODULATORS |
| FR2832930A1 (en) * | 2001-12-03 | 2003-06-06 | Lipha | PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF FOR THE PREPARATION OF MEDICINES FOR TREATING DIABETES |
| JP2004067575A (en) * | 2002-08-06 | 2004-03-04 | Yaizu Suisankagaku Industry Co Ltd | Promoter for effect of therapeutic agent for diabetes |
| CN101121004B (en) * | 2006-08-08 | 2010-07-21 | 鲁南制药集团股份有限公司 | Medicine composition containing insulin intensifier and miglitol |
| CN101584705B (en) * | 2008-05-24 | 2010-10-27 | 鲁南制药集团股份有限公司 | Medicament composition for treating diabetes and complications of diabetes |
| CN101584688B (en) * | 2008-05-24 | 2010-11-10 | 鲁南制药集团股份有限公司 | Medicament composition for treating diabetes and complications of diabetes |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06510286A (en) * | 1991-08-26 | 1994-11-17 | ファルマシア・アンド・アップジョン・カンパニー | Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone, glibenclamide or glimepiride |
| US5917052A (en) * | 1994-09-28 | 1999-06-29 | Shaman Pharmaceuticals, Inc. | Hypoglycemic agent from cryptolepis |
| TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
-
1998
- 1998-06-15 AU AU87999/98A patent/AU8799998A/en not_active Abandoned
- 1998-06-15 TR TR1999/03072T patent/TR199903072T2/en unknown
- 1998-06-15 PL PL98337577A patent/PL337577A1/en unknown
- 1998-06-15 AP APAP/P/1999/001720A patent/AP9901720A0/en unknown
- 1998-06-15 KR KR1019997011866A patent/KR20010013845A/en not_active Application Discontinuation
- 1998-06-15 CA CA002294134A patent/CA2294134A1/en not_active Abandoned
- 1998-06-15 CN CN98806319A patent/CN1274282A/en active Pending
- 1998-06-15 SK SK1794-99A patent/SK179499A3/en unknown
- 1998-06-15 WO PCT/EP1998/003691 patent/WO1998057635A1/en not_active Application Discontinuation
- 1998-06-15 BR BR9810186-2A patent/BR9810186A/en not_active IP Right Cessation
- 1998-06-15 IL IL13313898A patent/IL133138A0/en unknown
- 1998-06-15 JP JP50375699A patent/JP2001523271A/en not_active Ceased
- 1998-06-15 EP EP98939513A patent/EP0975343A1/en not_active Withdrawn
- 1998-06-15 EA EA200000040A patent/EA200000040A1/en unknown
- 1998-06-17 AR ARP980102882A patent/AR013352A1/en unknown
- 1998-06-17 DZ DZ980129A patent/DZ2519A1/en active
- 1998-06-17 AR ARP980102885A patent/AR014881A1/en unknown
- 1998-06-17 MA MA25121A patent/MA26510A1/en unknown
- 1998-06-18 PE PE1998000536A patent/PE89199A1/en not_active Application Discontinuation
- 1998-06-18 UY UY25051A patent/UY25051A1/en not_active Application Discontinuation
- 1998-06-18 CO CO98034648A patent/CO4940453A1/en unknown
- 1998-07-15 NZ NZ501345A patent/NZ501345A/en unknown
-
1999
- 1999-12-08 BG BG103966A patent/BG103966A/en unknown
- 1999-12-17 OA OA9900295A patent/OA11631A/en unknown
- 1999-12-17 NO NO996270A patent/NO996270D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ501345A (en) | 2001-10-26 |
| EP0975343A1 (en) | 2000-02-02 |
| AU8799998A (en) | 1999-01-04 |
| DZ2519A1 (en) | 2003-02-01 |
| SK179499A3 (en) | 2000-11-07 |
| PE89199A1 (en) | 1999-10-23 |
| WO1998057635A1 (en) | 1998-12-23 |
| BR9810186A (en) | 2000-08-08 |
| JP2001523271A (en) | 2001-11-20 |
| UY25051A1 (en) | 2000-09-29 |
| PL337577A1 (en) | 2000-08-28 |
| KR20010013845A (en) | 2001-02-26 |
| CA2294134A1 (en) | 1998-12-23 |
| CN1274282A (en) | 2000-11-22 |
| NO996270L (en) | 1999-12-17 |
| AP9901720A0 (en) | 1999-12-31 |
| MA26510A1 (en) | 2004-12-20 |
| AR014881A1 (en) | 2001-04-11 |
| CO4940453A1 (en) | 2000-07-24 |
| EA200000040A1 (en) | 2000-08-28 |
| OA11631A (en) | 2004-11-22 |
| AR013352A1 (en) | 2000-12-27 |
| BG103966A (en) | 2000-07-31 |
| TR199903072T2 (en) | 2000-07-21 |
| NO996270D0 (en) | 1999-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9901719A0 (en) | Treatment of diabetes with thiazolidinedione and metormin | |
| ZA9810788B (en) | Method and composition for the treatment and prevention of hyperuricemia | |
| AU5840200A (en) | Treatment of diabetes and related pathologies | |
| AU6435398A (en) | Prevention and treatment of hepatocellular cancer | |
| AP9901718A0 (en) | Treatment of diabetes with rosiglitazone and insulin | |
| IL133138A0 (en) | Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor | |
| HK1028200A1 (en) | Treatment of diabetes with thiazolidinedione and sulphonylurea | |
| IL134045A0 (en) | Treatment of diabetes with thiazolidinedione and sulphonylurea | |
| IL133907A0 (en) | Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor | |
| AU7688998A (en) | Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema | |
| AU4107797A (en) | Compounds for the treatment and prevention of diabetes | |
| HUP0002668A3 (en) | Treatment of diabetes with thiazolidinedione and metformin | |
| HUP0002669A3 (en) | Treatment of diabetes with thiazolidinedione and sulphonylurea | |
| IL121656A0 (en) | Diagnosis prevention and treatment of diabetes | |
| GB9618290D0 (en) | Treatment of diabetes | |
| ID24355A (en) | TREATMENT OF MELLITUS DIABETES WITH TIAZOLIDINADION AND ALFA-GLUCOSIDASE INHIBITORS | |
| GB9815149D0 (en) | Treatment of diabetes | |
| GB9812314D0 (en) | Treatment of diabetes | |
| GB9700481D0 (en) | Assay and method of treatment | |
| GB9609897D0 (en) | Treatment of diabetes | |
| GB9714804D0 (en) | Treatment of substrates | |
| GB9703008D0 (en) | Treatment of substrates | |
| GB9706608D0 (en) | Decontamination and treatment of metal surfaces |